Management Considerations for Patients at Risk of or With a Diagnosis of Breast Cancer
This advanced clinical course delivers an evidence-driven framework for hormone therapy management in women at risk for breast cancer or with an active or historical breast cancer diagnosis. The training emphasizes breast cancer risk stratification, hormone treatment selection, monitoring protocols, and clinical documentation to support safe, individualized, and defensible care in complex patient populations.

Review the “true data” from the WHI, with the significant outcomes that impact our treatment of women in relation to HRT replacement therapy.
This comprehensive webinar series reviews the real data surrounding HRT and breast cancer risk, cutting through outdated assumptions to focus on evidence-based clinical decision-making. Clinicians will explore hormone-related breast health, genitourinary symptoms of menopause, and practical management strategies—including which BHRT options may be safe and effective for patients with a history of or increased risk of breast cancer—grounded in real-world application and current research.
Do these challenges sound familiar?
1
Are you treating women with breast cancer risk who still require symptom management?
Designed for clinicians managing menopausal and perimenopausal patients whose breast cancer risk complicates hormone therapy decisions.
2
Do you struggle with conflicting or fear-based information about hormones and breast cancer?
Built for providers seeking evidence-driven training on hormone therapy risk, beyond media headlines and outdated clinical narratives.
3
Are you managing patients with active or historical breast cancer?
Ideal for clinicians treating women on endocrine therapy, post-treatment, or under cancer surveillance who require nuanced, risk-aware hormone management.
4
What you’ll take away from this course
- Breast Cancer Biology and Risk Stratification: Understand breast cancer subtypes, hormone receptor status, genetic risk factors, and how risk varies across patient populations.
- Hormone Therapy in High-Risk and Breast Cancer Patients: Learn evidence-driven considerations for estradiol, progesterone, testosterone, aromatase inhibitors, and intravaginal hormone therapies across risk categories.
- Clinical Management, Monitoring, and Informed Consent: Apply structured treatment strategies, dosing principles, laboratory monitoring, and documentation practices to support safe, defensible clinical care.
Designed for you to start using on day-one
Answer about breast cancer course goes here.
Top experts in your corner every step of the way

Dr. DeRosa, is a nationally recognized leader in hormonal health, committed to transforming medical education and patient care through hormone optimization. With over 25 years of experience as a physician, entrepreneur, and educator, she has dedicated her career to bridging the knowledge gap in hormone therapy, ensuring that both practitioners and patients have access to life changing treatment options.
Clinicians Companion Annual Certification Program
The Clinicians Companion Annual Certification Program (ACP) is an add-on for clinicians who have graduated the BHRT Masterclass. The ACP provides one year of ongoing education and support opportunities, and real-time resources that help you grow your skills, serve your patients better, and stay ahead of industry shifts.

Train Today. Treat Tomorrow.
Evidence-driven curriculum with clinical videos, dosing tools, case studies, downloadable dosing charts, protocols, quick reference guides and ongoing clinical support from foundation to advanced nuances.
Learn modern hormone therapy without access to the community, as as standalone course.